N@N

NaturalNano Engages NYC Based Investment Banking Firm as a Strategic Advisor for 2010

^{Published on 2009-12-29 10:00:28 - Market Wire}
 

ROCHESTER, NY--(Marketwire - December 29, 2009) - NaturalNano, Inc. (PINKSHEETS: [ NNAN ]) (FRANKFURT: N3N) announced today the engagement of an investment banking Firm in NYC as a strategic advisor to the Company on financing, market positioning, and potential strategic partnering.

Acting CEO and President James Wemett said that "NNAN has established this relationship to help with the on-going efforts of NNAN in the financial market place. As part of the program, they will assist in securing up to five million in capital for strategic initiatives and operating funds. This will allow us to grow our core Business of using Halloysite Natural Tubes (HNT) for improving products in the market and continue our efforts to identify acquisition opportunities that fit our capabilities and technologies."

James Wemett continues, "NaturalNano has been fortunate to have the support of our current financial partners and we look forward to establishing in concert more relationships with other investors. Strategic partnering, a priority, will allow NNAN to utilize its strong patent portfolio and technical know how."

About NaturalNano, Inc.

NaturalNano, Inc. (PINKSHEETS: [ NNAN ]) (FRANKFURT: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including their proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and licenses 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite. [ www.naturalnano.com ]

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.